ArticleCancer biomarkers : section A of Disease markers2022

Prognostic significance of a complement factor H autoantibody in early stage NSCLC.

Elizabeth B Gottlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.